Form 4 for KURA Kura Oncology, Inc.
Accepted 2023-06-21 00:00:00 ET · period of report 2023-06-16 · accession 0001209191-23-038797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-06-21 | 2023-06-16 | KURA | Malley Thomas | Dir | P - Purchase | $11.50 | +50.0K | 139.6K | +56% | +$575.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-06-16 | P | A | 50,000 | $11.50 | 139,557 | I By Mossrock Capital, LLC | — | — | (F1) Mr. Malley serves as President of Mossrock Capital, LLC and has sole voting and investment power over these shares. |